Australia markets closed

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
42.00-0.37 (-0.87%)
At close: 04:00PM EDT
42.00 0.00 (0.00%)
After hours: 04:49PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
7,287
8,083
8,612
3,637
0
-
Operating expenses
Research development
53,127
54,922
53,441
26,237
3,041
-
Selling general and administrative
27,019
26,140
22,262
10,329
1,802
-
Total operating expenses
80,146
81,062
75,703
36,566
4,843
-
Operating income or loss
-72,859
-72,979
-67,091
-32,929
-4,843
-
Interest expense
-
-
-
0
206
233
Total other income/expenses net
-
-
-
-
-1,735
-
Income before tax
-55,594
-58,293
-63,059
-32,672
-6,784
-
Income from continuing operations
-55,594
-58,293
-63,059
-32,672
-6,784
-
Net income
-55,594
-58,293
-63,059
-32,672
-6,784
-
Net income available to common shareholders
-55,594
-58,293
-63,059
-32,672
-6,784
-
Basic EPS
-1.52
-
-1.52
-1.39
-0.54
-0.62
Diluted EPS
-1.52
-
-1.52
-1.39
-0.54
-0.62
Basic average shares
41,470
-
41,470
23,530
12,473
6,415
Diluted average shares
41,470
-
41,470
23,530
12,473
6,415